Continuing medical education

CME Forum 2020: 5th Annual Advancements in Cancer Management

CME Forum is a live educational event designed to foster dialog between primary care providers (PCPs) and the oncology team, providing strategies that contribute to integrative care for patients with cancer. Panel discussions, case studies and Q & A sessions will take place over dinner to enhance clinician knowledge and competence. Click on the registration links to learn more about topics and faculty for each live event.

Advancements in Cancer Management

This program highlights 5 presentations from a 2019 spring live lecture series. Videos are packaged into short chapters, featuring topics such as: screening high-risk patients, cancer pain management, immunotherapy treatment & adverse event management, monitoring for the long-term effects of treatment and/or disease, combining integrative therapies with cancer treatment and drug-drug interactions.

Upon completion of this activity, participants will be able to:

• Explain the use of multimodal analgesia to manage pain and reduce the use of opioids
• Describe how integrative therapies and lifestyle change programs are employed as adjunct therapies in the care of patients with cancer
• Evaluate immuno-oncology approaches in cancer treatment, including patient selection
• Describe the appropriate follow-up protocols for identification of pulmonary nodules
• Recognize the pathophysiology and clinical presentations of various subtypes of pleural effusions
• Describe the various treatment options for each of the various pleural effusions

Faculty:

• Kevin Tulipana, DO, FHM (Cancer Treatment Centers of America)
• Stephen Lynch, MD (Cancer Treatment Centers of America)
• Lorenzo Cohen, PhD (The University of Texas MD Anderson Cancer Center)
• Vivek Iyer, MD (Cancer Treatment Centers of America)
• Larry Ladi, MD, FCCP (Cancer Treatment Centers of America)
• Timothy McCay, DO (Cancer Treatment Centers of America)
• Ankur Parikh, DO (Cancer Treatment Centers of America)

Lung Nodules: Evaluation and Diagnostic Approaches

Clinicians require education surrounding lung nodules and need to be updated on new and emerging therapies that will lead to individualized treatment and improved outcomes. As technology improves and new data emerges, recommendations for how and when to follow up with patients with lung nodules continues to evolve. This activity provides a platform to understand the latest guidance.

Upon completion of this activity, participants will be able to:

• Discuss the various diagnostic and staging procedures for lung nodules
• Select the appropriate approach and follow-up for high-risk patients with lung nodules

Faculty:

• Abdul Hamid Alraiyes, MD, FCCP (Cancer Treatment Centers of America)

Dysphagia Palliation in Esophageal Cancer

Expert faculty from CTCA and Banner MD Anderson recently gave a thought-provoking lecture on the management of dysphagia in patients with esophageal cancer as well as the effectiveness of emerging therapies used as monotherapy and in combination. Such insights and understandings are critical to advance patient care and optimize their health outcomes.

Upon completion of this activity, participants will be able to:

• Discuss the various modalities for management of dysphagia
• Select the appropriate modality for management of dysphagia in patients with esophageal cancer
• Explain the goals of palliative treatment in patients with esophageal cancer

Faculty:

• Toufic Kachaamy, MD, FASGE (Cancer Treatment Centers of America)
• Madappa Kundranda, MD, PhD (Banner MD Anderson)

Molecular Tumor Board Series 1

A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic testing, pathology and radiological imaging. Cases discussed include: squamous cell carcinoma of the scalp, papillary serous ovarian cancer, breast carcinoma and lung adenocarcinoma.

Upon completion of this activity, participants will be able to:

• Utilize skills learned to implement an effective tumor board.
• Describe genomic testing.
• Implement genomic profiling into oncology treatment.

Faculty:

• Pamela Crilley, DO (Cancer Treatment Centers of America)
• Ricardo H. Alvarez, MD, MSc (Cancer Treatment Centers of America)
• Shayma Master Kazmi, MD, RPh (Cancer Treatment Centers of America)
• Arturo Loaiza-Bonilla, MD (Cancer Treatment Centers of America)
• Maurie Markman, MD (Cancer Treatment Centers of America)
• Ankur R. Parikh, DO (Cancer Treatment Centers of America)
• Julian Schink, MD (Cancer Treatment Centers of America)
• Alan Tan, MD (Cancer Treatment Centers of America)

Molecular Tumor Board Series 3

A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic testing, pathology and radiological imaging. Cases discussed include: colon adenocarcinoma, endometrial adenocarcinoma and breast invasive ductal carcinoma (IDC).

Upon completion of this activity, participants will be able to:

• Utilize skills learned to implement an effective tumor board.
• Describe genomic testing.
• Implement genomic profiling into oncology treatment.

Faculty:

• Arturo Loaiza-Bonilla, MD, MSEd, FACP (Cancer Treatment Centers of America)
• Bradford Tan, MD (Cancer Treatment Centers of America)
• Scott Price, MD (Cancer Treatment Centers of America)
• Pamela Crilley, DO (Cancer Treatment Centers of America)
• Ankur Parikh, DO (Cancer Treatment Centers of America)
• Alan Tan, MD (Cancer Treatment Centers of America)
• Maurie Markman, MD (Cancer Treatment Centers of America)
• Ricardo Alvarez, MD, MSc (Cancer Treatment Centers of America)
• Julian Schink, MD (Cancer Treatment Centers of America)